NSAID (Non-selective COX Inhibitor)
Pregnancy: Avoid in third trimester (premature closure of ductus arteriosus, inhibition of labour). Short courses in first/second trimester with caution — preferably avoid. Paracetamol preferred.
Naproxen
Brand names: Naprosyn, Anaprox, Feminax Ultra
Adult dose
Dose: Pain/inflammation: 250–500mg BD; maximum 1g daily. Acute gout: 750mg initially, then 500mg every 8h until attack resolves (max 1250mg on day 1, then 1g daily). Dysmenorrhoea: 500mg initially, then 250mg every 6–8h (max 1250mg on day 1 then 1g daily).
Route: Oral
Frequency: Twice daily (standard dosing)
Max: 1250mg on first day (acute gout); 1g daily thereafter
Naproxen has a more favourable cardiovascular profile among NSAIDs — considered the lowest CV risk NSAID at standard doses (NICE recommendation). Longer half-life than ibuprofen — BD dosing preferred over TDS. Always prescribe with PPI (omeprazole 20mg OD) if >4 weeks use, age >45, or GI risk factors.
Paediatric dose
Dose: 5 mg/kg
Route: Oral
Frequency: Twice daily
Max: 1g daily
BNFc: Juvenile idiopathic arthritis (2–17 years): 5mg/kg BD (max 500mg BD). Seek specialist paediatric rheumatology opinion.
Dose adjustments
Renal
eGFR <30: avoid — NSAIDs worsen renal function; risk of AKI, fluid retention, and hyperkalaemia.
Hepatic
Severe hepatic impairment: avoid — reduced clearance, increased GI bleeding risk.
Paediatric weight-based calculator
BNFc: Juvenile idiopathic arthritis (2–17 years): 5mg/kg BD (max 500mg BD). Seek specialist paediatric rheumatology opinion.
Clinical pearls
- NICE CG177: naproxen preferred NSAID for patients with cardiovascular risk (lowest CV risk among NSAIDs at standard doses). Avoid diclofenac and etoricoxib in CV disease
- GI protection: co-prescribe omeprazole 20mg OD for all patients on NSAIDs aged >65, or with history of peptic ulcer, or on concurrent steroids/anticoagulants
- Triple whammy: NSAID + ACE inhibitor/ARB + diuretic = high risk of AKI — avoid this combination, particularly in elderly or volume-depleted patients
- Sick day rules: advise patients to stop naproxen when acutely unwell, fasting, or dehydrated — AKI risk
Contraindications
- Active peptic ulcer or GI bleeding
- eGFR <30
- Severe heart failure
- Third trimester of pregnancy
- CABG peri-operative
- Hypersensitivity to NSAIDs or aspirin (cross-reaction)
Side effects
- GI upset, peptic ulceration, GI bleeding
- AKI (particularly in volume-depleted patients)
- Fluid retention, oedema
- Hypertension
- Cardiovascular events (MI, stroke — at high doses/long-term)
- Bronchospasm (aspirin-sensitive asthma)
- Headache
- Rash
Interactions
- ACE inhibitors/ARBs — triple whammy with diuretics (AKI risk); avoid combination unless essential
- Warfarin — increased bleeding risk; monitor INR
- Lithium — NSAIDs increase lithium levels; monitor levels
- Methotrexate — NSAIDs reduce methotrexate excretion; toxicity risk
Monitoring
- eGFR and electrolytes (before starting and periodically)
- Blood pressure
- GI symptoms (gastroprotection adequacy)
- Oedema
Reference: BNFc; BNF 90; NICE CG177 (Osteoarthritis); NICE NG146 (Rheumatoid Arthritis). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- BALL Score for Relapsed/Refractory CLL · Leukaemia
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023